TOP TIERMARKET NEWSWIRE
News & sentiment

APREA THERAPEUTICS I (APRE) — News & AI sentiment

APREA THERAPEUTICS I (APRE) news roundup. 11 stories aggregated over the last 30 days. Average 30-day sentiment is 55.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
11
avg sentiment 55.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

APRE news in the last 24 hours, 7 days, 30 days and 90 days

How much APRE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAPRE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1155.9/100APRE headlines →
Last 90 days2456.7/100APRE headlines →

Latest stories on APRE

Nov 5
Nov 5
Aprea Therapeutics GAAP EPS of -$0.09 in-line
Seeking Alpha52 · neutralearnings
Nov 5
Nov 4
Nov 4
Nov 4
Nov 4
Nov 4
Oct 22
Oct 16
Oct 16
Oct 14
Aprea Therapeutics to Present at October Conferences
Business Insider55 · neutralgeneral
Oct 5
Oct 5
Sep 22
Sep 22
Sep 10
Aug 28
Aug 28
Aug 28
Aug 28
Aug 28
Aug 25
Aug 17
Aug 12
Open APRE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →